CAS: 1407495-04-8
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | Ralpancizumab REF: TM-T77140CAS: 1407495-04-8 | - - - | To inquire | Mon 02 Dec 24 |
 | Ralpancizumab REF: 3D-CLA1348CAS: 1407495-04-8 | - - - | To inquire | Thu 12 Dec 24 |
Ralpancizumab
CAS:1407495-04-8
Ralpancizumab, a selective PCSK9 inhibitor, shows potential for use in hemorrhagic stroke [1].
Color and Shape:
Liquid
Ref: TM-T77140
| 5mg | To inquire |
Estimated delivery in United States, on Monday 2 Dec 2024
Ralpancizumab
CAS:1407495-04-8
Anti-neural apoptosis-regulated proteinase 1 monoclonal antibody; treatment of dyslipidemia
Ref: 3D-CLA1348
| Undefined size | To inquire |
Estimated delivery in United States, on Thursday 12 Dec 2024
